Logo wahanariau.com
  2. Kyowa kirin

Kyowa kirin

Index
Globenewswire

Kyowa Kirin Announces Agreement with U.S. Administration to Reduce Treatment Costs for Americans

Selasa, 01 September 2026 - 22:17:53 Wib
Globenewswire

New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome

Rabu, 01 Juli 2026 - 21:57:11 Wib
Globenewswire

New PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome

Senin, 29 Juni 2026 - 22:31:46 Wib
Globenewswire

Kyowa Kirin to Present New Complementary Evidence Further Defining Clinical Utility of Mogamulizumab in Cutaneous T-Cell Lymphoma at 2026 WCCL

Rabu, 10 Juni 2026 - 21:39:32 Wib
Globenewswire

Kyowa Kirin and Kura Oncology Initiate Japanese Phase 2 Registration-Directed Trial of Ziftomenib in R/R NPM1-m AML

Jumat, 24 April 2026 - 21:24:12 Wib
Globenewswire

Kyowa Kirin Announces Discontinuation of Rocatinlimab Clinical Trials

Rabu, 04 Maret 2026 - 05:27:56 Wib
Globenewswire

Kyowa Kirin to Regain Control of Rocatinlimab Development and Commercialization Program, Demonstrating Strong Commitment to Address High Unmet Medical Need in Atopic Dermatitis

Jumat, 30 Januari 2026 - 20:03:30 Wib
Globenewswire

Kyowa Kirin Announces Late-Breaking Abstract Presentation at the European Academy of Dermatology and Venerology Congress

Kamis, 11 September 2025 - 19:30:00 Wib